Organization and Strategy at Millennium (A) Harvard Case Solution & Analysis

This case is the Millennium strategic and organizational responses to the rapid development of the biopharmaceutical industry. In the early 2000s, as a competitive advantage in the early stages of the Millennium Research slipped and its losses mounted, the founder and CEO Mark Levin firm moved downstream from the research and drug development and commercialization, while narrowing of the horizontal width of the more than a dozen therapeutic classes only three. In 2005, Levin hired Deborah Dunsire from Novartis as General Manager to lead the continuing transformation of the millennium. Students are asked to put themselves in the incoming CEO Dunsire and provide organizational recommendations for the new strategy. "Hide
by Julie M. Wolf, Scott Waggoner Source: HBS Premier Case Collection 22 pages. Publication Date: February 02, 2010. Prod. #: 710415-PDF-ENG

Related Case Solutions & Analyses:

Procter & Gamble in the 21st Century (C): Integrating Gillette Sarbanes-Oxley Act: Details and Evaluation Negotiating on Thin Ice: The 2004-2005 NHL Dispute (B) Lehman Brothers (D): Reemergence of the Equity Research Department Concept Testing Sermo, Inc. Venetian Republic & Portuguese Empire in the 16th Century SIX SIGMA AT ACADEMIC MEDICAL HOSPITAL (A) : AQUA Logistics Limited Endeavor: Miami Heats Up